Warangkana Munsakul

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Jintanat Ananworanich, Angèle Gayet‐Ageron, Michelle Le Braz et al. · The Lancet · 2006 · 240 citations · Full text

Pharmacy, Pharmacotherapy, Hiv Control +9

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

Torsak Bunupuradah, Ploenchan Chetchotisakd, Jintanat Ananworanich et al. · Antiviral Therapy · 2012 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

Praphan Phanuphak, Sasiwimol Ubolyam, Jongkol Sankote et al. · Antiviral Therapy · 2005 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Etravirine and Rilpivirine Resistance in HIV-1 Subtype Crf01_Ae-Infected Adults Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens

Torsak Bunupuradah, Jintanat Ananworanich, Ploenchan Chetchotisakd et al. · Antiviral Therapy · 2011 · 28 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Long-Term Efficacy and Safety of First-Line Therapy with Once-Daily Saquinavir/Ritonavir

Jintanat Ananworanich, Angèle Gayet‐Ageron, Kiat Ruxrungtham et al. · Antiviral Therapy · 2007 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17